Flying The Web For News.
  • Career Exam Study
    Career Exam Study
  • US Politics
    US Politics
  • E-commerce Guide
    E-commerce Guide
  • Dropshipping Guide
    Dropshipping Guide
  • Microsoft Exam
    Microsoft Exam
  • IT Career News
    IT Career News

Article Tools/Herramientas de artículos

+ Larger Font/Fuente más grande | - Smaller Font/Fuente más pequeña




Globe NewsWire News Distribution Service


SAN DIEGO, April 14, 2025 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Constellation Brands, Inc. (NYSE: STZ) securities between April 11, 2024 and January 8, 2025, both dates inclusive (the “Class Period”), have until Monday, April 21, 2025 to seek appointment as lead…


Posted: 2025-04-14 10:04:00

Get Full News Story On GlobeNewsWire Press Release Service



Listen to this article. Speaker link opens in a new window.
Text To Speech BETA Test Version.



Related Bing News Search Results

Press Release: INVESTOR DEADLINE APPROACHING: Robbins Geller Rudman & Dowd LLP Announces that Constellation Brands, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit – STZ - Newscast

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Iovance Biotherapeutics - KXAN Austin

Sun, 15 Jun 2025 09:20:00 GMT Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Iovance To Contact Him Directly To Discuss Their Options. If ...

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Krispy Kreme

Sun, 15 Jun 2025 08:25:00 GMT Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Krispy Kreme To Contact Him Directly To Discuss Their Options ...

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of PepGen

Sun, 15 Jun 2025 08:08:00 GMT On July 30, 2024, PepGen issued a press release announcing purported "positive clinical data from the first dose cohort (5 mg/kg) of PGN-EDO51" in its ongoing CONNECT1 study.

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of PepGen - KXAN Austin

Sun, 15 Jun 2025 08:08:00 GMT On July 30, 2024, PepGen issued a press release announcing purported "positive clinical data from the first dose cohort (5 mg/kg) of PGN-EDO51" in its ongoing CONNECT1 study.

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Open Lending | | news-journal.com

Sun, 15 Jun 2025 05:10:00 GMT Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Open Lending To Contact Him Directly To Discuss Their Options ...
Blow Us A Whistle




Related Product Search/Búsqueda de productos relacionados